Delivery Order 36F79718D0509-36C24922N0258

This is a Delivery Order contract awarded by the Veterans Integrated Service Network 5 (VISN 5), a defense agency, to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer. The contract is for the delivery of the drug BELZUTIFAN (WELIREG) 40 MG, which is used for cancer treatment. The contract has a ceiling value of $19,964.86 and is a Firm Fixed Price contract type. The contract is not set aside for any specific business category. Merck is a large for-profit...

This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 5, a civilian agency under the Department of Veterans Affairs, to Insmed Inc. for the drug BELZUTIFAN (WELIREG) 40 MG. The contract has a ceiling value of $10,105.41 and a completion date of February 17, 2025. Insmed Inc. is a global biopharmaceutical company that provides pharmaceuticals and drugs to the VA, including the antibiotic amikacin and the drug ARIKAYCE for the treatment of nontuberculous...

This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The $19,964.86 firm-fixed price contract is for the supply of the drug belzutifan (Welireg) 40 mg, which is used for cancer treatment. This order is placed under Merck's Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs. The contract has an ultimate completion date of October 9, 2024. Merck is a...

This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 23 (VISN 23) of the U.S. Department of Veterans Affairs (VA) to ASD Specialty Healthcare, LLC, a large pharmaceutical distribution company that is a subsidiary of AmerisourceBergen Corporation. The contract is for the emergency procurement of 40mg tablets of the cancer drug Welireg (belzutifan) with a ceiling value of $59,277.03 and a period of performance ending on August 1, 2022. ASD Specialty...

This is a delivery order contract awarded by the Veterans Integrated Service Network 20 (VISN 20), a civilian agency within the U.S. Department of Veterans Affairs, to Merck Sharp & Dohme LLC, doing business as Merck. The contract is for the pharmaceutical product Welireg (belzutifan), which is used for cancer treatment. The award has a ceiling value of $262,530.15 and is a firm fixed-price contract. The contract is not designated as a set-aside. Merck is a major pharmaceutical...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $677,821.50 firm fixed price delivery order against Neurocrine Biosciences, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract. This order is to provide VALBENAZINE 40MG and 80MG capsules for the Hines CMOP, indicating the capsules will support treatment programs at the Captain James A. Lovell Federal Health Care Center in Illinois. Neurocrine Biosciences will serve as the prime...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $14,515.04 firm fixed price delivery order to Actelion Pharmaceuticals US, Inc. for UPTRAVI 1400MCG. The order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) managed by the General Services Administration, with performance at a location in Bartlett, Tennessee. No set-aside designation was used for this order to supply the drug to support...

The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price purchase order to Mckesson Plasma And Biologics LLC, a subsidiary of Mckesson Corporation, for the delivery of belzutifan 40mg capsules. The contract, valued at $22,051.39, has an ultimate completion date of April 30, 2025. The award was made through the Veterans Integrated Service Network 2 (VISN 2), a regional network within the VA's healthcare system. The contract does not have a set-aside designation. Mckesson Plasma And...

The Department of Veterans Affairs Veterans Health Administration awarded a $10,868 delivery order against Recordati Rare Diseases, Inc.'s Pharmaceuticals and Drugs GSA Schedule to supply SIGNIFOR LAR 40 MG. The prime contractor will deliver the drug to a facility in Bartlett, Tennessee within the period of performance from October 11-13, 2023. Recordati Rare Diseases, Inc. will perform as the prime contractor under this firm fixed price contract issued by VA-VHA Network 5 to support its...

The Department of Veterans Affairs Veterans Health Administration awarded a $21,746.58 delivery order against Recordati Rare Diseases Inc.'s GSA Schedule contract for the pharmaceutical products SIGNIFOR LAR 20 & 40 MG. The prime contractor Recordati Rare Diseases Inc. will provide the drugs to VA facilities located in Bartlett, Tennessee over a two day period from December 12-14, 2023. The contract was awarded under Recordati's Pharmaceuticals and Drugs GSA Schedule, a multiple award IDIQ...